Durvalumab Plus Datopotamab Deruxtecan in Patients with PD-L1 Positive Advanced/metastatic Triplenegative Breast Cancer: Arm 8 of the Phase 1b/2, Open Label, Platform BEGONIA Study
CANCER RESEARCH（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要